Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 4 Thio D Ribose. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101200463B details a cost-effective D-glucose route for 4-thio-D-ribose intermediates, offering significant supply chain advantages over traditional L-lyxose methods.
Novel route from D-glucose reduces cost for 4-thio-nucleoside intermediates. High purity scalable process for antiviral drug synthesis.